Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Carbohydr Polym. 2013 Nov 6;98(2):1466-75. doi: 10.1016/j.carbpol.2013.07.023. Epub 2013 Jul 17.

A galactomannan polysaccharide from Punica granatum imparts in vitro and in vivo anticancer activity.

Author information

  • 1Division of Cancer Research, Regional Cancer Centre, Thiruvananthapuram 695 011, Kerala, India. Electronic address: manumjoseph2000@yahoo.com.

Abstract

Galactomannan polysaccharide (PSP001) was isolated from the fruit rind of Punica granatum and was previously reported to have excellent antioxidant and immunomodulatory properties. The cytotoxicity of PSP001 was evaluated in the human cancer cell lines A375, HCT116, and HepG2 as well as the murine cancer cell lines DLA and EAC over a wide range of concentrations. PSP001 exhibited significant cytotoxicity against cancer cells through the induction of apoptosis with no in vivo toxicity up to a concentration of 2000 mg/kg body weight when assessed in BALB/c mice. The antitumor efficacy of PSP001 was tested in DLA and EAC murine ascites and EAC solid tumor mouse models. PSP001 alone and in combination with doxorubicin produced a significant reduction in the tumor burden and increased life span in both models compared to the controls. The results suggest that PSP001 has the potential to be developed as an anticancer agent either alone or as an adjuvant to chemotherapy.

Copyright © 2013 Elsevier Ltd. All rights reserved.

KEYWORDS:

Cancer; Dalton's lymphoma ascites; Ehrlich's ascites carcinoma; Polysaccharide; Punica granatum

PMID:
24053828
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk